Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	32821
Country	United Kingdom

Received	2017-01-26 21:02
Peer-Review Started	2017-01-28 20:11
To Make the First Decision	2017-03-06 18:01
Return for Revision	2017-03-08 08:56
Revised	2017-03-15 00:31
Second Decision	2017-04-12 18:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-04-24 10:34
Articles in Press	2017-04-24 10:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-04-28 10:03
Publish the Manuscript Online	2017-05-04 08:16

ISSN	2150-5349 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Frontier
Article Title	5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
Manuscript Source	Invited Manuscript
All Author List	Morris Gordon
Funding Agency and Grant Number
Corresponding Author	Dr. Morris Gordon, School of Medicine and Dentistry, University of Central Lancashire, University of Central Lancashire, HA118, Harrington Building, Preston PR1 2HE, United Kingdom. morris@betterprescribing.com
Key Words	5-Aminosalicylate; Systematic review; Crohn’s disease; Inflammatory bowel disease; Cochrane
Core Tip	This paper proposes that the varying length of remission and disease activity of patients enrolled in studies for medically induced remission is different to surgical induced remission and may explain differences in findings. This guides future research proposals. Future primary research is needed in the medical induced remission setting which considers the length of remission on enrolment and endoscopic or histological disease scores. Additionally, secondary research to rank the various treatment options in the post-surgical setting could be achieved through the use of network meta-analysis.
Publish Date	2017-05-04 08:16
Citation	Gordon M. 5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence. World J Gastrointest Pharmacol Ther 2017; 8(2): 99-102
URL	http://www.wjgnet.com/2150-5349/full/v8/i2/99.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v8.i2.99

Full Article (PDF)	WJGPT-8-99.pdf
Full Article (Word)	WJGPT-8-99.doc
Manuscript File	32821-Review.doc
Answering Reviewers	32821-Answering reviewers.pdf
Audio Core Tip	32821-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	32821-Conflict-of-interest statement.pdf
Copyright License Agreement	32821-Copyright assignment.pdf
Peer-review Report	32821-Peer-review(s).pdf
Scientific Misconduct Check	32821-Scientific misconduct check.pdf
Scientific Editor Work List	32821-Scientific editor work list.pdf